{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T02:50:42Z","timestamp":1648954242789},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,8,18]],"date-time":"2009-08-18T00:00:00Z","timestamp":1250553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s11908-009-0051-1","type":"journal-article","created":{"date-parts":[[2009,8,16]],"date-time":"2009-08-16T19:30:14Z","timestamp":1250451014000},"page":"357-364","source":"Crossref","is-referenced-by-count":2,"title":["Hemodynamic resuscitation in septic shock: Cardiovascular support and adjunctive therapy"],"prefix":"10.1007","volume":"11","author":[{"given":"Brian M.","family":"Fuller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Phillip","family":"Dellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,18]]},"reference":[{"key":"51_CR1","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"E. Rivers","year":"2001","unstructured":"Rivers E, Nguyen B, Havstad S, et al.; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368\u20131377.","journal-title":"N Engl J Med"},{"key":"51_CR2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A.M. Kumar","year":"2006","unstructured":"Kumar AM, Roberts DM, Wood KED, et al.: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589\u20131596.","journal-title":"Crit Care Med"},{"key":"51_CR3","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/01.CCM.0000057403.73299.A6","volume":"31","author":"R.P. Dellinger","year":"2003","unstructured":"Dellinger RP: Cardiovascular management of septic shock. Crit Care Med 2003, 31:946\u2013955.","journal-title":"Crit Care Med"},{"key":"51_CR4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00003246-199901000-00053","volume":"27","author":"P.T.L. Choi","year":"1999","unstructured":"Choi PTL, Yip G, Quinonez LG, Cook DJ: Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999, 27:200\u2013210.","journal-title":"Crit Care Med"},{"key":"51_CR5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.316.7136.961","volume":"316","author":"G. Schierhout","year":"1998","unstructured":"Schierhout G, Roberts I: Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomized trials. BMJ 1998, 316:961\u2013964.","journal-title":"BMJ"},{"key":"51_CR6","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa040232","volume":"350","author":"S. Finfer","year":"2004","unstructured":"Finfer S, Bellomo R, Boyce N, et al.: SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247\u20132256.","journal-title":"N Engl J Med"},{"key":"51_CR7","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1097\/01.CCM.0000239119.57544.0C","volume":"34","author":"M.J. Dubois","year":"2006","unstructured":"Dubois MJ, Orellana-Jimenez C, Melot C, et al.: Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 2006, 34:2536\u20132540.","journal-title":"Crit Care Med"},{"key":"51_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","volume":"34","author":"R.P. Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17\u201360.","journal-title":"Intensive Care Med"},{"key":"51_CR9","first-page":"61","volume":"90","author":"J.E. Calvin","year":"1981","unstructured":"Calvin JE, Driedger AA, Sibbald WJ: The hemodynamic effect of rapid fluid infusion in critically ill patients. Surgery 1981, 90:61\u201376.","journal-title":"Surgery"},{"key":"51_CR10","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1378\/chest.98.6.1450","volume":"98","author":"C. Reuse","year":"1990","unstructured":"Reuse C, Vincent JL, Pinsky MR: Measurements of right ventricular volumes during fluid challenge. Chest 1990, 98:1450\u20131454.","journal-title":"Chest"},{"key":"51_CR11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0002-8703(88)90256-6","volume":"116","author":"A.J. Schneider","year":"1988","unstructured":"Schneider AJ, Teule GJJ, Groeneveld ABJ, et al.: Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: a combined hemodynamic and radionuclide study. Am Heart J 1988, 116:103\u2013112.","journal-title":"Am Heart J"},{"key":"51_CR12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archsurg.1992.01420070081015","volume":"127","author":"L.N. Diebel","year":"1992","unstructured":"Diebel LN, Wilson RF, Tagett MG, et al.: End-diastolic volume: a better indicator of preload in the critically ill. Arch Surg 1992, 127:817\u2013822.","journal-title":"Arch Surg"},{"key":"51_CR13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/00005373-199412000-00014","volume":"37","author":"L. Diebel","year":"1994","unstructured":"Diebel L, Wilson RF, Heins J, et al.: End-diastolic volume vs pulmonary artery wedge pressure in evaluating cardiac preload in trauma patients. J Trauma 1994, 37:950\u2013955.","journal-title":"J Trauma"},{"key":"51_CR14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/00000542-199812000-00007","volume":"89","author":"B. Tavernier","year":"1998","unstructured":"Tavernier B, Makhotine O, Lebuffe G, et al.: Systolic pressure variation as a guide to fluid therapy in patients with sepsis-induced hypotension. Anesthesiology 1998, 89:1313\u20131321.","journal-title":"Anesthesiology"},{"key":"51_CR15","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1378\/chest.113.4.1048","volume":"113","author":"J.G. Wagner","year":"1998","unstructured":"Wagner JG, Leatherman JW: Right ventricular end-diastolic volume as a predictor of the hemodynamic response to a fluid challenge. Chest 1998, 113:1048\u20131054.","journal-title":"Chest"},{"key":"51_CR16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/01.CCM.0000114996.68110.C9","volume":"32","author":"A. Kumar","year":"2004","unstructured":"Kumar A, Anel R, Bunnell E, et al.: Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volumes, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med 2004, 32:691\u2013699.","journal-title":"Crit Care Med"},{"key":"51_CR17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.CCM.0000249851.94101.4F","volume":"35","author":"D. Osman","year":"2007","unstructured":"Osman D, Ridel C, Ray P, et al.: Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med 2007, 35:64\u201368.","journal-title":"Crit Care Med"},{"key":"51_CR18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0883-9441(92)90032-3","volume":"7","author":"S. Magder","year":"1992","unstructured":"Magder S, Georgiadis G, Cheong T, et al.: Respiratory variations in right atrial pressure predict the response to fluid challenge. J Crit Care 1992, 7:76\u201385.","journal-title":"J Crit Care"},{"key":"51_CR19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1164\/ajrccm.162.1.9903035","volume":"162","author":"F. Michard","year":"2000","unstructured":"Michard F, Boussat S, Chemla D, et al.: Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med 2000, 162:134\u2013138.","journal-title":"Am J Respir Crit Care Med"},{"key":"51_CR20","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/00000542-199812000-00007","volume":"89","author":"B. Tavernier","year":"1998","unstructured":"Tavernier B, Makhotine O, Lebuffe G, et al.: Systolic pressure variation as a guide to fluid therapy in patients with sepsis induced hypotension. Anesthesiology 1998, 89:1313\u20131321.","journal-title":"Anesthesiology"},{"key":"51_CR21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/bja\/aei262","volume":"95","author":"S. Preisman","year":"2005","unstructured":"Preisman S, Kogan S, Berkenstadt H, et al.: Predicting fluid responsiveness in patients undergoing cardiac surgery: functional haemodynamic parameters including the respiratory systolic variation test and static preload indicators. Br J Anaesth 2005, 95:746\u2013755.","journal-title":"Br J Anaesth"},{"key":"51_CR22","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/bja\/ael250","volume":"97","author":"H. Solus-Biguenet","year":"2006","unstructured":"Solus-Biguenet H, Fleyfel M, Tavernier B, et al.: Noninvasive prediction of fluid responsiveness during major hepatic surgery. Br J Anaesth 2006, 97:808\u2013816.","journal-title":"Br J Anaesth"},{"key":"51_CR23","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1097\/01.CCM.0000215453.11735.06","volume":"34","author":"X. Monnet","year":"2006","unstructured":"Monnet X, Rienzo M, Osman D, et al.: Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med 2006, 34:1402\u20131407.","journal-title":"Crit Care Med"},{"key":"51_CR24","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00134-007-0642-y","volume":"33","author":"J. Maizel","year":"2007","unstructured":"Maizel J, Airapetian N, Lorne E, et al.: Diagnosis of central hypovolemia by using passive leg raising. Intensive Care Med 2007, 33:1133\u20131138.","journal-title":"Intensive Care Med"},{"key":"51_CR25","doi-asserted-by":"crossref","first-page":"R132","DOI":"10.1186\/cc5044","volume":"10","author":"A. Lafanechere","year":"2006","unstructured":"Lafanechere A, Pene F, Goulenok C, et al.: Changes in aortic blood flow induced by passive leg raising predict fluid responsiveness in critically ill patients. Crit Care 2006, 10:R132.","journal-title":"Crit Care"},{"key":"51_CR26","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/01.CCM.0000132904.35713.A7","volume":"32","author":"H.B. Nguyen","year":"2004","unstructured":"Nguyen HB, Rivers EP, Knoblich BP: Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004, 32:1637\u20131642.","journal-title":"Crit Care Med"},{"key":"51_CR27","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1378\/chest.07-0291","volume":"132","author":"S.M. Hollenberg","year":"2007","unstructured":"Hollenberg SM: Vasopressor support in septic shock. Chest 2007, 132:1678\u20131687.","journal-title":"Chest"},{"key":"51_CR28","first-page":"650","volume":"3","author":"A.D. Bersten","year":"1995","unstructured":"Bersten AD, Holt AW: Vasoactive drugs and the importance of renal perfusion pressure. New Horiz 1995, 3:650\u2013661.","journal-title":"New Horiz"},{"key":"51_CR29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00586523","volume":"410","author":"H.R. Kirchheim","year":"1987","unstructured":"Kirchheim HR, Ehmke H, Hackenthal E, et al.: Autoregulation of renal blood flow, glomerular filtration rate and renin release in conscious dogs. Pflugers Arch 1987, 410:441\u2013449.","journal-title":"Pflugers Arch"},{"key":"51_CR30","doi-asserted-by":"crossref","unstructured":"LeDoux D, Astiz ME, Carpati CM, Rackow EC: Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000 28 :2729\u20132732.","DOI":"10.1097\/00003246-200008000-00007"},{"key":"51_CR31","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.CCM.0000157788.20591.23","volume":"33","author":"A. Bourgoin","year":"2005","unstructured":"Bourgoin A, Leone M, Delmas A, et al.: Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 2005, 33:780\u2013786.","journal-title":"Crit Care Med"},{"key":"51_CR32","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00134-005-2688-z","volume":"31","author":"M. Varpula","year":"2005","unstructured":"Varpula M, Tallgren M, Saukkonen K, et al.: Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005, 31:1066\u20131071.","journal-title":"Intensive Care Med"},{"key":"51_CR33","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(07)61344-0","volume":"370","author":"D. Annane","year":"2007","unstructured":"Annane D, Vigno P, Renault A, et al.: Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomized trial. Lancet 2007, 370:676\u2013684.","journal-title":"Lancet"},{"key":"51_CR34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"J.A. Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, et al.: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877\u2013887.","journal-title":"N Engl J Med"},{"key":"51_CR35","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJMe0800245","volume":"358","author":"J.E. Parrillo","year":"2008","unstructured":"Parrillo JE: Septic shock-vasopressin, norepinephrine, and urgency. N Engl J Med 2008, 358:954\u2013956.","journal-title":"N Engl J Med"},{"key":"51_CR36","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","volume":"288","author":"D. Annane","year":"2002","unstructured":"Annane D, Sebille V, Charpentier C, et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862\u2013871.","journal-title":"JAMA"},{"key":"51_CR37","doi-asserted-by":"crossref","unstructured":"Briegel J, Forst H, Haller M, et al.: Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999 27 :723\u2013732.","DOI":"10.1097\/00003246-199904000-00025"},{"key":"51_CR38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","volume":"26","author":"P.E. Bollaert","year":"1998","unstructured":"Bollaert PE, Charpentier C, Levy B, et al.: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998, 26:645\u2013650.","journal-title":"Crit Care Med"},{"key":"51_CR39","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","volume":"32","author":"R.P. Dellinger","year":"2004","unstructured":"Dellinger RP, Carlet JM, Masur H, et al.: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32:858\u2013873.","journal-title":"Crit Care Med"},{"key":"51_CR40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"C.L. Sprung","year":"2008","unstructured":"Sprung CL, Annane D, Keh D, et al.: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111\u2013124.","journal-title":"N Engl J Med"},{"key":"51_CR41","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","volume":"36","author":"P.E. Marik","year":"2008","unstructured":"Marik PE, Pastores SM, Annane D, et al.: Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008, 36:1937\u20131949.","journal-title":"Crit Care Med"},{"key":"51_CR42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/QCO.0b013e32818be70a","volume":"20","author":"I. Cinel","year":"2007","unstructured":"Cinel I, Dellinger RP: Advance in pathogenesis and management of sepsis. Curr Opin Inect Dis 2007, 20:345\u2013352.","journal-title":"Curr Opin Inect Dis"},{"key":"51_CR43","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"G.R. Bernard","year":"2001","unstructured":"Bernard GR, Vincent JL, Laterre PF, et al.: Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699\u2013709.","journal-title":"N Engl J Med"},{"key":"51_CR44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00003246-200301000-00002","volume":"31","author":"E.W. Ely","year":"2003","unstructured":"Ely EW, Laterre PF, Angus DC, et al.: Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med 2003, 31:12\u201319.","journal-title":"Crit Care Med"},{"key":"51_CR45","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa050935","volume":"353","author":"E. Abraham","year":"2005","unstructured":"Abraham E, Laterre PF, Garg R, et al.: Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group: Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005, 353:1332\u20131341.","journal-title":"N Engl J Med"},{"key":"51_CR46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.CCM.0000298309.73776.CB","volume":"36","author":"A. Wheeler","year":"2008","unstructured":"Wheeler A, Steingrub J, Schmidt GA, et al.: A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: comparison with a controlled clinical trial. Crit Care Med 2008, 36:14\u201323.","journal-title":"Crit Care Med"},{"key":"51_CR47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00134-007-0555-9","volume":"33","author":"S. Kanji","year":"2007","unstructured":"Kanji, S, Perreault MM, Chant C, et al.: Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: a Canadian multicenter observational study. Intensive Care Med 2007, 33:517\u201323.","journal-title":"Intensive Care Med"},{"key":"51_CR48","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1097\/01.CCM.0000220498.48773.3C","volume":"34","author":"D. Backer De","year":"2006","unstructured":"De Backer D, Verdant C, Chierego M, et al.: Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. Crit Care Med 2006, 34:1918\u20131924.","journal-title":"Crit Care Med"},{"key":"51_CR49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1553-2712.2008.00109.x","volume":"15","author":"S. Trzeciak","year":"2008","unstructured":"Trzeciak S, Cinel I, Dellinger RP, et al.: Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008, 15:399\u2013413.","journal-title":"Acad Emerg Med"},{"key":"51_CR50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/TA.0b013e3180eeab28","volume":"65","author":"A. Chapital","year":"2008","unstructured":"Chapital A, Yu M, Ho H, et al.: Using transcutaneous oxygen pressure measurements as selection criteria for activated protein C use. J Trauma 2008, 65:30\u201333.","journal-title":"J Trauma"},{"key":"51_CR51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1164\/rccm.200612-1803OC","volume":"176","author":"M. Levi","year":"2007","unstructured":"Levi M, Levy M, Williams MD, et al.: Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated). Am J Respir Crit Care Med 2007, 176:483\u2013490.","journal-title":"Am J Respir Crit Care Med"},{"key":"51_CR52","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G. Berghe van den","year":"2001","unstructured":"van den Berghe G, Wouters P, Weekers F, et al.: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359\u20131367.","journal-title":"N Engl J Med"},{"key":"51_CR53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa052521","volume":"354","author":"G. Berghe van den","year":"2006","unstructured":"van den Berghe G, Wilmer A, Hermans G, et al.: Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449\u2013461.","journal-title":"N Engl J Med"},{"key":"51_CR54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"F.M. Brunkhorst","year":"2008","unstructured":"Brunkhorst FM, Engel C, Bloos F, et al.: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125\u2013139.","journal-title":"N Engl J Med"},{"key":"51_CR55","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/cc6807","volume":"12","author":"M.M. Treggiari","year":"2008","unstructured":"Treggiari MM, Karir V, Yanez ND, et al.: Intensive insulin therapy and mortality in critically ill patients. Crit Care 2008, 12:R29.","journal-title":"Crit Care"},{"key":"51_CR56","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jama.300.8.933","volume":"300","author":"R.S. Wiener","year":"2008","unstructured":"Wiener RS, Wiener DC, Larson RJ: Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008, 300:933\u2013944.","journal-title":"JAMA"},{"key":"51_CR57","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","volume":"360","author":"S. Finfer","year":"2009","unstructured":"NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, et al.: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283\u20131297.","journal-title":"N Engl J Med"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-009-0051-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-009-0051-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-009-0051-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:22:11Z","timestamp":1559420531000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-009-0051-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,18]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1007\/s11908-009-0051-1","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,18]]}}}